Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 72 (4) , 725-735
Abstract
No abstract availableKeywords
Funding Information
- A*STAR Biomedical Research Council
- Bayer AG
- National Medical Research Council (NMRC/MOHIAFCAT2/001/2014, NMRC/OFLCG/003/2018)
- Biomedical Research Council (BMRC/IAF311020/2016)
This publication has 43 references indexed in Scilit:
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- The Proline Regulatory Axis and CancerFrontiers in Oncology, 2012
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesisNature Genetics, 2011
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- Molecular targeted therapies in hepatocellular carcinoma†Hepatology, 2008
- Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stressFree Radical Biology and Medicine, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003